RE: 8th Eswi Influenza Conference7 Dec 2021 07:06
Taverham
Not sue if you’re aware, but there was a presentation or something last night?
Southampton, UK - 6 December 2021: Synairgen plc (LSE: SNG), the respiratory company developing SNG001, a formulation for inhalation containing the broad-spectrum antiviral protein interferon beta for ‘the treatment of severe viral lung infections.’
Even if P3 readout isn’t as good as expected, this will not just crash to zero. Hence, the info delivered last night. I would guess that we will lose 30-60% with a very poor set of results.
BJW, will therefore still have plenty of capital to reinvest if it goes pear shaped.
Anyone invested at this point, that expects it to go pear shaped, shouldn’t be invested anyway.
DYOR